Vilanterol
Vilanterol
Definition
A long-acting beta-2 adrenergic agonist, with bronchodilator activity. Upon administration, vilanterol stimulates beta-2 adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP concentrations relax bronchial smooth muscle, relieve bronchospasms, and reduce inflammatory cell mediator release, especially from mast cells.
Also known as GW 642444, GW-642444, GW642444, VILANTEROL — per NCIT
Also identified as
- NCIT NCIT:C152875 per NCIT
- SCTID 702408004 per RXNORM
- SCTID 720194004 per RXNORM
- UNII 028LZY775B per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Obstructive sleep apnea syndrome | may treat | MEDRT · Public domain (U.S. Government work) |